• Mo Jain - novel technologies for biomarker discovery

  • Oct 24 2023
  • Duración: 37 m
  • Podcast

Mo Jain - novel technologies for biomarker discovery

  • Resumen

  • Mo Jain, Founder and CEO of Sapient, discusses the importance of small molecule biomarkers and his approach to biomarker discovery research.

    The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics.

    https://www.bioinformaticscro.com/

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Mo Jain - novel technologies for biomarker discovery

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.